Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2005-02-01
2010-02-16
Landau, Sharmila Gollamudi (Department: 1611)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
C514S212070, C514S212080
Reexamination Certificate
active
07662956
ABSTRACT:
The present application relates to novel tetrahydrobenzo[d]azepin-2-one derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, especially of dyslipidaemias, arteriosclerosis, restenosis and ischaemias.
REFERENCES:
patent: 6537987 (2003-03-01), Hamanaka et al.
patent: 2003/0078251 (2003-04-01), Kori et al.
patent: WO 97/48701 (1997-12-01), None
patent: WO 02/057258 (2002-07-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Pandit et al. Journal of Biological Chemistry, “Crystal Structure of Human Squalene Synthase” vol. 275(39) 2000, 30610-30617.
G. Assmann et al.: “The Münster Heart Study (PROCAM),” European Heart Journal, vol. 19, Supp. A., 1998, pp. A2-A11.
N. S. Watson et al.: “7 Squalene Synthase Inhibitors: Their Potential as Hypocholesterolaemic Agents,” Progress in Medicinal Chemistry, vol. 33, 1996, pp. 331-378.
H. Hiyoshi et al.: “Squalene Synthase Inhibitors Reduce Plasma Triglyceride Through a Low-Density Lipoprotein Receptor-Independent Mechanism,” European Journal of Pharmacology, vol. 431, 2001, pp. 345-352.
Bischoff Hilmar
Buchmüller Anja
Ellinghaus Peter
Flessner Timo
Griebenow Nils
Bayer Shering Pharma AG
Edwards Angell Palmer & & Dodge LLP
Klinkel Kortney L
Kramer Barry
Landau Sharmila Gollamudi
LandOfFree
Tetrahydrobenzo[d]azepin-2-one derivatives and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrobenzo[d]azepin-2-one derivatives and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrobenzo[d]azepin-2-one derivatives and the use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4205729